Stealth drug research earns big award - WKOW 27: Madison, WI Breaking News, Weather and Sports

Stealth drug research earns big award

Madison (WKOW) -- from UW Madison:  A proposal to create a stealth drug, one that remains cloaked inside a cell until activated by a pathogen, has snared a high-profile $100,000 award from the Bill & Melinda Gates Foundation.

  University of Wisconsin-Madison biochemist Ron Raines' proposal to the Gates Foundation's Grand Challenges in Global Health initiative beat 40-to-1 funding odds and is aimed broadly at developing therapeutic agents that limit drug resistance.

  The idea floated by Raines and his group involves creating a novel cytotoxin, an agent poisonous to cells, from an enzyme known as a ribonuclease whose job is to cleave RNA.

  By making an inactive precursor form of the RNA-slicing enzyme, Raines says, it's possible to deliver the agent to cells where it can reside benignly until activated by a pathogen such as HIV.

  In the case of HIV infection, the cloak, Raines explains, is removable only by a protein-slicing enzyme that the pathogen requires to complete its life cycle.

  "As that cleavage can only occur in cells infected with the HIV-1 virus, the toxic activity of the ribonuclease will be unleashed only in infected cells," he said.

  A therapy that kills only HIV-infected cells has the potential to eradicate in patients the reservoir where the virus does its dirty work.

  The strategy, Raines adds, could also be used as a prophylactic, preventing the virus from getting a foothold in the cells it commandeers to make new virus particles.

  The approach, according to Raines, could also be used to develop strategies for combating pathogens in addition to HIV.

Powered by Frankly